Protecting Kids from Pneumonia Alexandria VA

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule) in Alexandria.

Davita-Alexandria Dialysis Center
(703) 751-6115
5999 Stevenson Avenue
Alexandria, VA
 
Jon M Farber
(703) 212-6600
4660 Kenmore Ave
Alexandria, VA
Specialty
Pediatrics

Data Provided by:
Shahinodokht Parvin, MD
(703) 971-8686
6275 Franconia Rd
Alexandria, VA
Specialties
Pediatrics
Gender
Female
Education
Medical School: Isfahan Univ, Fac Of Med, Isfahan, Iran
Graduation Year: 1966

Data Provided by:
Evie Kalli Cavros, MD
(703) 971-6900
6255 Harbin Dr
Alexandria, VA
Specialties
Pediatrics
Gender
Female
Education
Medical School: Eastern Va Med Sch Of The Med Coll Of Hampton Roads, Norfolk Va 23501
Graduation Year: 1991

Data Provided by:
Dr. Erwin Allen Bondareff
(703) 924-2100
6355 Walker Ln Ste 401
Alexandria, VA
Specialty
Pediatrics

Malhotra Suresh Dr
(703) 823-0333
4660 Kenmore Avenue Suite 810
Alexandria, VA
 
Dr. Denise Tunstall Balistreri
(703) 212-6600
4660 Kenmore Ave Ste 500
Alexandria, VA
Specialty
Pediatrics

Dr. Lisa A Goldberg
(703) 504-3069
4320 Seminary Rd Ste 3000
Alexandria, VA
Specialty
Pediatrics

Nancy Jenkins Leykam, MD
(703) 971-6900
7015C Manchester Blvd
Alexandria, VA
Specialties
Pediatrics
Gender
Female
Education
Medical School: Univ Of Va Sch Of Med, Charlottesville Va 22908
Graduation Year: 1989
Hospital
Hospital: Inova Fairfax Hospital, Falls Church, Va
Group Practice: Wwm Pediatrics

Data Provided by:
Dr. Rosario Gonsalez Dancel
(703) 823-2400
6000 Stevenson Ave
Alexandria, VA
Specialty
Pediatrics

Data Provided by:

Protecting Kids from Pneumonia

Provided By:

Parents and babies alike will be relieved by new findings that show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule). But factors such as questions about the cost-effectiveness of the current PCV-7 dose schedule have led researchers to examine reduced-dose vaccine schedules, according to background information in the study.

The researchers, Dr. Elske J.M. van Gils, of the University Medical Center Utrecht in the Netherlands, and colleagues, studied 1,003 healthy infants who were randomly assigned to receive two doses of PCV-7 at 2 months and 4 months of age, or a 2 + 1-dose schedule at 2, 4 and 11 months of age, or no vaccine (control group). The children were checked after 12 months, 18 months and 24 months for pneumococcal microorganisms in the upper part of the throat behind the nose.

Compared to those in the control group, children in both vaccine groups had far lower rates of microorganisms that can cause pneumonia and other infections, according to the report in the July 8 issue of the Journal of the American Medical Association.

"In conclusion, both two-dose and 2 + 1-dose schedules of PCV-7 significantly reduce vaccine serotype pneumococcal carriage in children. This study supports future implementation of reduced-dose PCV-7 schedules," the researchers concluded.

More information

The Nemours Foundation has more about children and pneumonia.

SOURCE: Journal of the American Medical Association, news release, July 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com